200,000+ products from a single source!
sales@angenechem.com
CAS No: 1282041-94-4 Catalog No: AG000XUT MDL No:
Title | Journal |
---|---|
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. | The Lancet. Infectious diseases 20180801 |
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study. | The Lancet. Infectious diseases 20170601 |
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection. | The Lancet. Infectious diseases 20170601 |
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. | Science translational medicine 20150715 |
© 2019 Angene International Limited. All rights Reserved.